Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)

被引:25
|
作者
Bookhout, Christine [1 ]
Bouldin, Thomas W. [1 ]
Ellison, David W. [2 ]
机构
[1] Univ N Carolina, Dept Surg Pathol, Chapel Hill, NC 27599 USA
[2] St Jude Childrens Res Hosp, Dept Neuropathol, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
atypical teratoid; rhabdoid tumor; BRG1; INI1; SMARCA4; SMARCB1; CENTRAL-NERVOUS-SYSTEM; MALIGNANT RHABDOID TUMOR; SMALL-CELL-CARCINOMA; PREDISPOSITION SYNDROME; HYPERCALCEMIC TYPE; HSNF5/INI1; MUTATIONS; GERMLINE; CLASSIFICATION; PROGNOSIS;
D O I
10.1111/neup.12452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, highly aggressive malignancy of the central nervous system (CNS) usually diagnosed in infancy or childhood, most often characterized by loss of expression of the SMARCB1 gene product integrase interactor 1 (INI1) protein. We report a case of AT/RT in a 3month old boy with retained expression of INI1 by immunohistochemistry. Additional testing demonstrated loss of expression of the SMARCA4 gene product Brahma-related gene 1 (BRG1) protein by immunohistochemistry, confirmed by next generation sequencing showing a nonsense mutation in SMARCA4. This case illustrates that positivity for INI1 does not rule out a diagnosis of AT/RT, and additional testing, including BRG1/SMARCA4 analysis, is warranted in cases where clinical suspicion is high.
引用
下载
收藏
页码:305 / 308
页数:4
相关论文
共 50 条
  • [31] Loss of BRG1/SMARCA4 Expression in Pancreatic Ductal Adenocarcinoma
    Lin, M.
    Scrimieri, F.
    Nguyen, T.
    Wolfgang, C. L.
    Iacobuzio-Donahue, C.
    Maitra, A.
    Goggins, M.
    Eshleman, J.
    Olino, K.
    Kern, S. E.
    Hruban, R. H.
    LABORATORY INVESTIGATION, 2010, 90 : 363A - 363A
  • [32] BRG1 and INI1 expression in metastatic melanoma
    Flotte, T.
    Bell, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 74 - 74
  • [33] Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 (hSNF5/INI1)
    Peterson, Jo Elle G.
    Bavle, Abhishek
    Mehta, Vidya P.
    Rauch, Ronald A.
    Whitehead, William E.
    Mohila, Carrie A.
    Su, Jack M.
    Adesina, Adekunle M.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2019, 22 (02) : 161 - 165
  • [34] Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression
    Kohashi, Kenichi
    Nakatsura, Tetsuya
    Kinoshita, Yoshiaki
    Yamamoto, Hidetaka
    Yamada, Yuichi
    Tajiri, Tatsuro
    Taguchi, Tomoaki
    Iwamoto, Yukihide
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2013, 44 (04) : 526 - 533
  • [35] Loss of SMARCB1/INI1 Expression in Pediatric Poorly Differentiated Chordomas
    Clark, L.
    Gokden, M.
    Saad, A. G.
    LABORATORY INVESTIGATION, 2012, 92 : 429A - 429A
  • [36] Loss of SMARCB1/INI1 Immunoexpression in Chordoid Meningiomas
    Malgulwar, Prit B.
    Kakkar, Aanchal
    Sharma, Mehar C.
    Ghosh, Ranajoy
    Pathak, Pankaj
    Sarkar, Chitra
    Suri, Vaishali
    Singh, Manmohan
    Kale, Shashank S.
    Faruq, Mohammed
    NEUROLOGY INDIA, 2019, 67 (06) : 1492 - 1497
  • [37] Loss of SMARCB1/INI1 Expression in Pediatric Poorly Differentiated Chordomas
    Clark, L.
    Gokden, M.
    Saad, A. G.
    MODERN PATHOLOGY, 2012, 25 : 429A - 429A
  • [38] SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features
    Cho, Yong Mee
    Choi, Jene
    Lee, Ok-Jun
    Lee, Hyang-Im
    Han, Duck Jong
    Ro, Jae Y.
    PATHOLOGY INTERNATIONAL, 2006, 56 (11) : 702 - 706
  • [39] Expression of SMARCB1 (INI1) mutations in familial schwannomatosis
    Smith, Miriam J.
    Walker, James A.
    Shen, Yiping
    Stemmer-Rachamimov, Anat
    Gusella, James F.
    Plotkin, Scott R.
    HUMAN MOLECULAR GENETICS, 2012, 21 (24) : 5239 - 5245
  • [40] Spectrum of SMARCB1/INI1 Mutations in Familial and Sporadic Rhabdoid Tumors
    Eaton, Katherine W.
    Tooke, Laura S.
    Wainwright, Luanne M.
    Judkins, Alexander R.
    Biegel, Jaclyn A.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (01) : 7 - 15